4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-008508
SVP, Head of Global Commercial gave up 1,216 shares (to pay taxes)
- SVP, Head of Global Commercial acquired 12,313 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Porter Derrell SVP, Head of Global Commercial | 2019-02-06 | Shares withheld for taxes | −1,216 | $38.47 | $46,780 | 11,284 | D |
| Porter Derrell SVP, Head of Global Commercial | 2019-02-06 | Grant or award | −12,313 | 23,597 | D | ||
| Derivatives | |||||||
| Porter Derrell SVP, Head of Global Commercial | 2019-02-06 | Grant or award · Employee Stock Option (Right to Buy) | +24,625 | 24,625 | D | ||
Loading xslF345X03/doc4.xml…